{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T10:26:23Z","timestamp":1778063183418,"version":"3.51.4"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Low back pain (LBP) is one of the most prevalent chronic pain conditions that affects nearly 50% of the population. Its complex pathophysiology may involve both nociceptive and neuropathic mechanisms and is often resistant to standard treatment. Pregabalin has emerged as a potential alternative owing to its mechanism of action, the inhibition of excitatory neurotransmitter release. This meta-analysis aimed to evaluate the efficacy and safety of pregabalin in managing LBP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic review of three major databases was conducted following the PRISMA guidelines. Studies were included if they were comparative studies of pregabalin with placebo or other pain medications, focusing on adult patients with LBP. Data were extracted on efficacy outcomes including pain reduction, anxiety, depression, quality of life, quality of sleep, disability, and adverse events. Statistical analysis was performed using Review Manager 5.4.1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 18 studies (<jats:italic>n =<\/jats:italic> 5,000) were included. Pregabalin demonstrated significant pain reduction at 4\u00a0weeks (Standardized Mean Difference (SMD) = \u22120.64, 95% Confidence Interval (CI) = \u22121.09 to \u22120.20), 6\u00a0weeks (SMD = \u22120.72, 95% CI = \u22121.15 to \u22120.29), and 8\u00a0weeks (SMD = \u22120.50, 95% CI = \u22120.71 to \u22120.29) compared to control group. Pregabalin also showed a significant greater improvement in anxiety (Mean Difference (MD) = \u22121.38, 95% CI = \u22121.74 to \u22121.02, p &amp;lt; 0.00001), depression (MD = \u22121.40, 95% CI = \u22121.71 to \u22121.08, p &amp;lt; 0.00001), quality of life (SMD = 0.22, 95% CI = 0.07 to 0.37, p = 0.003) and sleep quality (SMD = \u22120.61, 95% CI = \u22120.87 to \u22120.36, p &amp;lt; 0.00001). There were no significant differences regarding disability and adverse events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Pregabalin in the treatment of neuropathic LBP demonstrated significant improvements in pain relief, associated symptoms of anxiety and depression, and enhancements in quality of life and sleep quality. In addition, it exhibits a favorable safety profile. Nevertheless, these findings should be interpreted with caution due to the limited quality of the evidence and the inadequate reporting of pain etiology in several included studies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1659531","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:06:07Z","timestamp":1757325967000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of pregabalin in the management of low back pain: a comprehensive meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Carlos","family":"Cordero\u2010Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"S\u00e1nchez\u2010Raya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara L.","family":"Rodr\u00edguez\u2010Araya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"L\u00f3pez\u2010Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Trillo\u2010Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jer\u00f3nimo","family":"Balsalobre\u2010Aznar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"P\u00e9rez\u2010P\u00e1ramo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3340\/jkns.2022.0225","article-title":"Pregabalin versus gabapentin efficacy in the management of neuropathic pain associated with failed back surgery syndrome","volume":"67","author":"Al-Ameri","year":"2024","journal-title":"J. Korean Neurosurg. Soc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"102709","DOI":"10.1016\/j.msksp.2022.102709","article-title":"Impact on productivity impairment of a digital care program for chronic low back pain: a prospective longitudinal cohort study","volume":"63","author":"Areias","year":"2023","journal-title":"Musculoskelet. Sci. Pract."},{"key":"B3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.pain.2010.04.013","article-title":"The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy","volume":"150","author":"Baron","year":"2010","journal-title":"Pain"},{"key":"B4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/papr.12200","article-title":"Effectiveness and safety of tapentadol prolonged release (PR) versus a combination of tapentadol PR and pregabalin for the management of severe, chronic low back pain with a neuropathic component: a randomized, double-blind, phase 3b study","volume":"15","author":"Baron","year":"2014","journal-title":"Pain Pract."},{"key":"B5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/ejp.838","article-title":"Neuropathic low back pain in clinical practice","volume":"20","author":"Baron","year":"2016","journal-title":"Eur. J. Pain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"CD013815","DOI":"10.1002\/14651858.CD013815.pub2","article-title":"Pharmacological treatments for low back pain in adults: an overview of Cochrane reviews","volume":"4","author":"Cashin","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.surneu.2007.05.046","article-title":"Percutaneous pulsed radiofrequency in the treatment of cervical and lumbar radicular pain","volume":"70","author":"Chao","year":"2008","journal-title":"Surg. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e33932","DOI":"10.1097\/MD.0000000000033932","article-title":"Efficacy and safety of pulsed radiofrequency combined with pregabalin for herpetic neuralgia: a systematic review and meta-analysis","volume":"102","author":"Chen","year":"2023","journal-title":"Medicine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12888-023-04581-7","article-title":"Prevalence and economic burden of depression and anxiety symptoms among Singaporean adults: results from a 2022 web panel","volume":"23","author":"Chodavadia","year":"2023","journal-title":"BMC Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s00586-020-06605-2","article-title":"Healthcare expenditure and its predictors in a cohort of Australians living with sciatica","volume":"30","author":"Chye","year":"2021","journal-title":"Eur. Spine J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.spinee.2007.10.005","article-title":"A systematic review of low back pain cost of illness studies in the United States and internationally","volume":"8","author":"Dagenais","year":"2008","journal-title":"Spine J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/ijerph18010341","article-title":"Health(care) in the crisis: reflections in science and society on opioid addiction","volume":"18","author":"Damiescu","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/pm\/pnac170","article-title":"Do chronic low back pain and chronic widespread pain differ in their association with depression symptoms in the 1958 British birth cohort?","volume":"24","author":"Dickson","year":"2023","journal-title":"Pain Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"CD012087","DOI":"10.1002\/14651858.CD012087","article-title":"Non-steroidal anti-inflammatory drugs for chronic low back pain","volume":"2","author":"Enthoven","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1080\/03007995.2018.1552042","article-title":"Current understanding of the mixed pain concept: a brief narrative review","volume":"35","author":"Freynhagen","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"key":"B16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jclinane.2016.01.010","article-title":"A randomized placebo-controlled study of preoperative pregabalin for postoperative analgesia in patients with spinal surgery","volume":"31","author":"Fujita","year":"2016","journal-title":"J. Clin. Anesth."},{"key":"B17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2174\/1574887116666210201110507","article-title":"The clinical difference between Gabapentin and pregabalin: data from a pilot comparative trial","volume":"16","author":"Gammoh","year":"2021","journal-title":"Recent Pat. Biotechnol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1016\/S2665-9913(23)00098-X","article-title":"Global, regional, and national burden of low back pain, 1990\u20132020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev-pharmtox-051421-112259","article-title":"Neuropathic pain: mechanisms, sex differences, and potential therapies for a global problem","volume":"63","author":"Ghazisaeidi","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"102144","DOI":"10.1016\/j.aprim.2021.102144","article-title":"A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain","volume":"54","author":"Gim\u00e9nez-Campos","year":"2022","journal-title":"Aten. Primaria"},{"key":"B21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"Findings tables and evidence profiles\u2014continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J. Clin. Epidemiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1009950","DOI":"10.3389\/fphar.2022.1009950","article-title":"Risk of major adverse events associated with gabapentinoid and opioid combination therapy: a systematic review and meta-analysis","volume":"13","author":"Hahn","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"B24","doi-asserted-by":"publisher","first-page":"878865","DOI":"10.3389\/fpubh.2022.878865","article-title":"Anxiety symptoms and associated factors among chronic low back pain patients in China: a cross-sectional study","volume":"10","author":"Hu","year":"2022","journal-title":"Front. Public Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jns.2014.05.002","article-title":"An open labeled randomized controlled trial of pregabalin versus amitriptyline in chronic low backache","volume":"342","author":"Kalita","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/pm\/pnaa421","article-title":"A retrospective database study of gastrointestinal events and medical costs associated with nonsteroidal anti-inflammatory drugs in Japanese patients of working age with osteoarthritis and chronic low back pain","volume":"22","author":"Kikuchi","year":"2021","journal-title":"Pain Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.spinee.2016.02.049","article-title":"Comparative study of the efficacy of limaprost and pregabalin as single agents and in combination for the treatment of lumbar spinal stenosis: a prospective, double-blind, randomized controlled non-inferiority trial","volume":"16","author":"Kim","year":"2016","journal-title":"Spine J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3390\/jcm13051188","article-title":"Predictive factors of functional outcomes and quality of life in patients with ankle fractures: a systematic review","volume":"13","author":"Lorente","year":"2024","journal-title":"J. Clin. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.3390\/ijerph18052693","article-title":"Neuropathic low back pain and burnout among Hungarian workers","volume":"18","author":"M\u00e1k","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.0000000000001168","article-title":"Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication","volume":"84","author":"Markman","year":"2015","journal-title":"Neurology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.drudis.2018.06.004","article-title":"Why are there no drugs indicated for sciatica, the most common chronic neuropathic syndrome of all?","volume":"23","author":"Markman","year":"2018","journal-title":"Drug Discov. Today"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1007\/s00586-023-07857-4","article-title":"Effectiveness of pharmacological and non-pharmacological therapy on pain intensity and disability in older people with chronic nonspecific low back pain: a systematic review with meta-analysis","volume":"32","author":"Mascarenhas","year":"2023","journal-title":"Eur. Spine J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1614292","article-title":"Trial of pregabalin for acute and chronic sciatica","volume":"376","author":"Mathieson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"12148","DOI":"10.1038\/s41598-022-16146-x","article-title":"Pregabalin administration in patients with fibromyalgia: a Bayesian network meta-analysis","volume":"12","author":"Migliorini","year":"2022","journal-title":"Sci. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1049909111412539","article-title":"A comparative efficacy of amitriptyline, Gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study","volume":"29","author":"Mishra","year":"2012","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13548506.2025.2478657","article-title":"From acute to chronic low back pain: the role of negative emotions","author":"Monta\u00f1o","year":"2025","journal-title":"Psychol. Health Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2165\/11536280-000000000-00000","article-title":"A cost-consequence analysis of pregabalin versus usual care in the symptomatic treatment of refractory low back pain: sub-analysis of observational trial data from orthopedic surgery and rehabilitation clinics","volume":"30","author":"Morera-Dom\u00ednguez","year":"2010","journal-title":"Clin. Drug Investig."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e221478","DOI":"10.1148\/radiol.221478","article-title":"CT-guided pulsed radiofrequency combined with steroid injection for sciatica from herniated disk: a randomized trial","volume":"307","author":"Napoli","year":"2023","journal-title":"Radiology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e694","DOI":"10.1016\/j.wneu.2024.04.033","article-title":"Comparative study on the efficacy of pregabalin versus limaprost in patients with lumbar spinal stenosis: a prospective, randomized controlled trial","volume":"186","author":"Park","year":"2024","journal-title":"World Neurosurg."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2147\/JPR.S157856","article-title":"Comparison of the efficacy and safety of pregabalin for postherpetic neuralgia in Chinese and international patients","volume":"11","author":"Parsons","year":"2018","journal-title":"J. Pain Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12909-021-02544-8","article-title":"Sleepiness, sleep deprivation, quality of life, mental symptoms and perception of academic environment in medical students","volume":"21","author":"Perotta","year":"2021","journal-title":"BMC Med. Educ."},{"key":"B43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/ejp.1519","article-title":"Opioids for chronic low back pain: an updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks of double-blind duration","volume":"24","author":"Petzke","year":"2020","journal-title":"Eur. J. Pain"},{"key":"B44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2217\/pmt.11.71","article-title":"Combination therapy with transdermal buprenorphine and pregabalin for chronic low back pain","volume":"2","author":"Pota","year":"2012","journal-title":"Pain Manag."},{"key":"B45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/jamaneurol.2018.3077","article-title":"Effect of gabapentin vs pregabalin on pain intensity in adults with chronic sciatica: a randomized clinical trial","volume":"76","author":"Robertson","year":"2019","journal-title":"JAMA Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10195-009-0077-z","article-title":"Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain","volume":"10","author":"Roman\u00f2","year":"2009","journal-title":"J. Orthop. Traumatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00586-015-3812-6","article-title":"Pharmacological management of chronic low back pain in older patients: a randomized controlled trial of the effect of pregabalin and opioid administration","volume":"24","author":"Sakai","year":"2015","journal-title":"Eur. Spine J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00296-009-1086-1","article-title":"Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings","volume":"30","author":"Salda\u00f1a","year":"","journal-title":"Rheumatol. Int."},{"key":"B49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1533-2500.2009.00312.x","article-title":"A cost-consequences analysis of the effect of pregabalin in the treatment of painful radiculopathy under medical practice conditions in primary care settings","volume":"10","author":"Salda\u00f1a","year":"","journal-title":"Pain Pract."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1002369","DOI":"10.1371\/journal.pmed.1002369","article-title":"Benefits and safety of gabapentinoids in chronic low back pain: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Shanthanna","year":"2017","journal-title":"PLoS Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2519\/jospt.2022.11145","article-title":"Low back pain in low- and middle-income countries, part 1: the problem","volume":"52","author":"Sharma","year":"2022","journal-title":"J. Orthop. Sports Phys. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3233\/WOR-205300","article-title":"Prevalence of low back pain in India: a systematic review and meta-analysis","volume":"73","author":"Shetty","year":"2022","journal-title":"Work"},{"key":"B53","first-page":"372","article-title":"Cost comparison of adding pregabalin or gabapentin for the first time to the therapy of patients with painful axial radiculopathy treated in Spain","volume":"31","author":"Sicras-Mainar","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J. Surg."},{"key":"B55","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2147\/JPR.S88642","article-title":"Effectiveness of pregabalin for the treatment of chronic low back pain with accompanying lower limb pain (neuropathic component): a non-interventional study in Japan","volume":"8","author":"Taguchi","year":"2015","journal-title":"J. Pain Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (Alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40266-022-00929-y","article-title":"Opioids and falls risk in older adults: a narrative review","volume":"39","author":"Virnes","year":"2022","journal-title":"Drugs Aging"},{"key":"B58","doi-asserted-by":"publisher","first-page":"101786","DOI":"10.1016\/j.xcrm.2024.101786","article-title":"Clinical pain management: current practice and recent innovations in research","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e072962","DOI":"10.1136\/bmj-2022-072962","article-title":"Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis","volume":"380","author":"Wewege","year":"2023","journal-title":"BMJ"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s40122-022-00437-2","article-title":"Efficacy and safety of pregabalin prolonged release-etoricoxib combination compared to etoricoxib for chronic low back pain: phase 3, randomized study","volume":"11","author":"Yeole","year":"2022","journal-title":"Pain Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2147\/NDT.S3257","article-title":"New treatment options in the management of fibromyalgia: role of pregabalin","volume":"4","author":"Zareba","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/aas.12420","article-title":"Efficacy and safety of pregabalin for treating painful diabetic peripheral neuropathy: a meta-analysis","volume":"59","author":"Zhang","year":"2015","journal-title":"Acta Anaesthesiol. Scand."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1659531\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:06:13Z","timestamp":1757325973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1659531\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":62,"alternative-id":["10.3389\/fphar.2025.1659531"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1659531","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"article-number":"1659531"}}